No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
Onexton is a topical acne drug developed by Ortho Dermatologics, a division of Bausch Health Companies Inc. It is a combination of two active ingredients, clindamycin phosphate and benzoyl peroxide, which work together to reduce the number of acne lesions. The drug is available in a gel form and is applied directly to the affected area. It is indicated for the treatment of mild to moderate acne vulgaris in patients 12 years of age and older.
Onexton is part of a larger market of acne drugs, which includes both prescription and over-the-counter medications. These drugs are used to treat a variety of acne-related conditions, including blackheads, whiteheads, pimples, and cysts. Common active ingredients in these medications include benzoyl peroxide, salicylic acid, and retinoids.
The Onexton market is highly competitive, with a number of companies offering similar products. These include Galderma, Johnson & Johnson, GlaxoSmithKline, and Allergan. Other companies, such as Curology and Proactiv, offer over-the-counter acne treatments. Show Less Read more
